[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341109-105":59,"doc-detail-341109-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rac1-as-a-potential-pan-cancer-diagnostic-prognostic-and-immunological-biomarker","RAC1 as a potential pan-cancer diagnostic - prognostic, and immunological biomarker","","Ras-related C3 botulinum toxin substrate 1 (RAC1) is evaluated as a solid-tumor biomarker with pan-cancer diagnostic, prognostic, and immunological relevance. Analyses integrate TCGA, GTEx, cBioPortal, TIMER2, and published datasets to assess RAC1 expression across cancers and its links to DNA methylation, immune infiltration, immune-related genes, tumor mutational burden, and microsatellite instability. A prognostic nomogram for liver hepatocellular carcinoma is built from RAC1-GTP expression and validated using immunohistochemistry.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rac1-as-a-potential-pan-cancer-diagnostic-prognostic-and-immunological-biomarker/341109/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rac1-as-a-potential-pan-cancer-diagnostic-prognostic-and-immunological-biomarker/341109.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does RAC1 play in tumors according to the background section?","Question",{"text":112,"@type":113},"RAC1 is described as part of the Rho GTPase family involved in tumorigenesis. The document notes that its cross-cancer clinical utility in solid tumors is unclear, motivating the study.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were RAC1 associations investigated in the methods?",{"text":117,"@type":113},"The study analyzes multiple public databases (TCGA, GTEx, cBioPortal, TIMER2) and published articles. For liver hepatocellular carcinoma, a prognostic nomogram is developed from RAC1-GTP expression and validated using immunohistochemistry.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings about RAC1 expression and patient outcomes?",{"text":121,"@type":113},"RAC1 is reported as highly expressed across most cancers and correlated with prognosis and pathological stages. Significant links are found between RAC1 and methylation, immune infiltration, immune-related genes, tumor mutational burden, and microsatellite instability, and LIHC tissues show higher RAC1-GTP protein than normal tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341109,1790619402,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","RAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker  \nLinglong Tao1,2\\#, Xiaoyu Xu1,2\\#, Zhengxuying Fang1,2, Petros Christopoulos3,4, Diego Cortinovis5, Yi Lu1^  \n1Department of Radiation Oncology, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, China; 2Health Science Center, Ningbo University, Ningbo, China; 3Department of Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, Heidelberg, Germany; 4Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Heidelberg, Germany; 5SC Medical Oncology/SS Lung Unit, Fondazione IRCCS San Gerardo dei Tintori Monza, Monza, Italy  \nContributions: (I) Conception and design: L Tao, Y Lu; (II) Administrative support: Y Lu; (III) Provision of study materials or patients: L Tao, X Xu;  \n(IV) Collection and assembly of data: L Tao, X Xu; (V) Data analysis and interpretation: L Tao, X Xu, Z Fang; (VI) Manuscript writing: All authors;(VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Yi Lu, PhD. Department of Radiation Oncology, The Affiliated Lihuili Hospital, Ningbo University, Jiangnan Road 1111\\#, Ningbo  \n315040, [China. Email: ybyb1980@zju.edu.cn](China. Email: ybyb1980@zju.edu.cn).  \nBackground: Ras-related C3 botulinum toxin substrate 1 (RAC1) is an important member of the Rho GTPase family involved in tumorigenesis. However, its role and potential clinical utility across cancer  \nentities in solid tumors is unknown.  \nMethods: We analyzed data from various databases, including The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression Project, cBioPortal, Tumor Immune Estimation Resource 2 (TIMER2), and published articles. A prognostic nomogram for liver hepatocellular carcinoma (LIHC) patients was developed based on RAC1-guanosine triphosphate (GTP) gene expression levels, which were validated using  \nimmunohistochemistry (IHC) .  \nResults: In this study, RAC1 was highly expressed in most cancers and correlated with prognosis and pathological stages. Furthermore, significant associations were observed between RAC1 and DNA methylation, immune cell infiltration, immune-related genes, tumor mutational burden, and microsatellite instability in most tumors. As a use case, we employed gene set enrichment analysis (GSEA) and gene set variation analysis (GSVA) to analyze the biologic importance of RAC1 expression and established a prognostic nomogram based on tumor stage and RAC1 expression, which can better predict the overall survival rate of patients with LIHC better than tumor stage alone. The gene expression results were validated with IHC, which confirmed a higher expression of the RAC1-GTP protein in LIHC compared to  \nparacancerous tissues.  \nConclusions: This extensive solid tumor analysis provides sound evidence that RAC1 can serve as both as  \nan immunotherapy target and as a diagnostic and prognostic biomarker.  \nKeywords: Ras-related C3 botulinum toxin substrate 1 (RAC1); solid tumors; liver hepatocellular carcinoma  \n(LIHC); prognostic analysis; immunotherapy  \nSubmitted Jan 16, 2024. Accepted for publication Mar 21, 2024. Published online Mar 27, 2024.  \ndoi: 10.21037/tcr-23-2016  \nView this article at: [https://dx.doi.org/10.21037/tcr-23-2016](https://dx.doi.org/10.21037/tcr-23-2016)  \n^ ORCID: 0000-0002-2240-6824.  \n© Translational Cancer Research. All rights reserved. Transl Cancer Res 2024;13(3):1533-1553 | [https://dx.doi.org/10.21037/tcr-23-2016](https://dx.doi.org/10.21037/tcr-23-2016)  \n1534 Tao, et al. RAC1 as a potential pan-cancer biomarker  \nIntroduction  \nCancer has become a global health crisis, impacting millions of people worldwide, with increasing morbidity and mortality (1) . Cancer not only causes suffering to individuals but also imposes a considerable economic burden on society (2) . Over the past decade, even with improvements in the diagnosis and treatm","cbCair7eEbHgherj","https://ap.wps.com/l/cbCair7eEbHgherj","pdf",10174459,21,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Key findings","[{\"question\":\"What role does RAC1 play in tumors according to the background section?\",\"answer\":\"RAC1 is described as part of the Rho GTPase family involved in tumorigenesis. The document notes that its cross-cancer clinical utility in solid tumors is unclear, motivating the study.\"},{\"question\":\"How were RAC1 associations investigated in the methods?\",\"answer\":\"The study analyzes multiple public databases (TCGA, GTEx, cBioPortal, TIMER2) and published articles. For liver hepatocellular carcinoma, a prognostic nomogram is developed from RAC1-GTP expression and validated using immunohistochemistry.\"},{\"question\":\"What were the main findings about RAC1 expression and patient outcomes?\",\"answer\":\"RAC1 is reported as highly expressed across most cancers and correlated with prognosis and pathological stages. Significant links are found between RAC1 and methylation, immune infiltration, immune-related genes, tumor mutational burden, and microsatellite instability, and LIHC tissues show higher RAC1-GTP protein than normal tissues.\"}]","RAC1 as a potential pan-cancer diagnostic - prognostic, and immunological biomarker | PDF",1790040363,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d00d6d66078387ca94cf7d124c9fde6.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d41fc46ae21bdcc11b7960cf17af7e75.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec693563cc6252cd97f2b25626639e07.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a461dfe9de4f41773fcdc513df06328f.webp",980,1283]